source
- Endpoints launches nominations for its 2026 Women in Biopharma projectEndpoints announced that nominations are now open for its eighth annual Women in Biopharma initiative, which highlights contributions of women in the industry. The program, scheduled for 2026, see…
- Tango to launch Phase 3 trial in pancreatic cancer after promising combo resultsTango announced plans to begin a Phase 3 trial testing a combination therapy for pancreatic cancer. The decision follows data presented at the American Society of Clinical Oncology meeting, where…